Kinaxis Inc.
Kinaxis Inc. (KXSCF) Financial Performance & Income Statement Overview
Analyze Kinaxis Inc. (KXSCF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Kinaxis Inc. (KXSCF) Income Statement & Financial Overview
Explore comprehensive income reports for Kinaxis Inc. KXSCF, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $132.79M | $123.94M | $121.53M | $118.28M |
| Cost of Revenue | $46.25M | $48.83M | $45.16M | $48.09M |
| Gross Profit | $86.54M | $75.10M | $76.36M | $70.19M |
| Gross Profit Ratio | $0.65 | $0.61 | $0.63 | $0.59 |
| R&D Expenses | $22.67M | $21.31M | $21.14M | $22.22M |
| SG&A Expenses | $43.54M | $56.80M | $47.62M | $43.17M |
| Operating Expenses | $68.22M | $78.11M | $68.75M | $67.83M |
| Total Costs & Expenses | $114.47M | $126.94M | $113.92M | $115.92M |
| Interest Income | $0.00 | $0.00 | $0.00 | $3.12M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $5.42M | $6.05M | $6.21M | $6.27M |
| EBITDA | $23.74M | $3.04M | $13.82M | $8.63M |
| EBITDA Ratio | $0.18 | $0.02 | $0.11 | $0.07 |
| Operating Income | $18.32M | -$3.004M | $7.61M | $2.36M |
| Operating Income Ratio | $0.14 | -$0.02 | $0.06 | $0.02 |
| Other Income/Expenses (Net) | $3.34M | $3.76M | $2.48M | $3.15M |
| Income Before Tax | $21.65M | $752000.00 | $10.09M | $5.52M |
| Income Before Tax Ratio | $0.16 | $0.006 | $0.08 | $0.05 |
| Income Tax Expense | $5.74M | $17.07M | $3.34M | $2.08M |
| Net Income | $15.91M | -$16.32M | $6.75M | $3.43M |
| Net Income Ratio | $0.12 | -$0.13 | $0.06 | $0.03 |
| EPS | $0.57 | -$0.58 | $0.24 | $0.12 |
| Diluted EPS | $0.55 | -$0.57 | $0.23 | $0.12 |
| Weighted Avg Shares Outstanding | $28.09M | $28.23M | $28.23M | $28.62M |
| Weighted Avg Shares Outstanding (Diluted) | $28.79M | $28.81M | $28.81M | $28.79M |
Over the past four quarters, Kinaxis Inc. demonstrated steady revenue growth, increasing from $118.28M in Q2 2024 to $132.79M in Q1 2025. Operating income reached $18.32M in Q1 2025, maintaining a consistent 14% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $23.74M, reflecting operational efficiency. Net income rose to $15.91M, with EPS at $0.57. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan